Orsolya Modos
Budapest, BU 1082, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Efficacy of immune checkpoint inhibitor therapy for advanced urothelial carcinoma in real-life clinical practice: results of a multicentric, retrospective study.
Journal: Scientific reports
Published: May 10, 2023
Current diagnostic and treatment strategies for urachal cancer
Journal: Orvosi hetilap
Published: January 31, 2023
Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas.
Journal: Cancer medicine
Published: September 20, 2022
Comparative proteome analysis identified CD44 as a possible serum marker for docetaxel resistance in castration-resistant prostate cancer.
Journal: Journal of cellular and molecular medicine
Published: May 31, 2021
High Serum PD-L1 Levels Are Associated with Poor Survival in Urothelial Cancer Patients Treated with Chemotherapy and Immune Checkpoint Inhibitor Therapy.
Journal: Cancers
Published: March 19, 2021
Soluble Syndecan-1 Levels Are Associated with Survival in Platinum-Treated Bladder Cancer Patients.
Journal: Diagnostics (Basel, Switzerland)
Published: September 16, 2020
Prevalence of APC and PTEN Alterations in Urachal Cancer.
Journal: Pathology oncology research : POR
Published: March 02, 2020
Characteristics of bladder recurrence after radical nephroureterectomy in upper urinary tract cancer
Characteristics of bladder recurrence after radical nephroureterectomy in upper urinary tract cancer
Journal: Orvosi hetilap
Published: December 15, 2019
STIP1 Tissue Expression Is Associated with Survival in Chemotherapy-Treated Bladder Cancer Patients.
STIP1 Tissue Expression Is Associated with Survival in Chemotherapy-Treated Bladder Cancer Patients.
Journal: Pathology oncology research : POR
Published: April 18, 2019
Validation of survivin and HMGA2 as biomarkers for cisplatin resistance in bladder cancer.
Journal: Urologic oncology
Published: February 07, 2019
Matrix metalloproteinase 7, soluble Fas and Fas ligand serum levels for predicting docetaxel resistance and survival in castration-resistant prostate cancer.
Journal: BJU international
Published: May 27, 2018
Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas.
Journal: International journal of cancer
Published: October 29, 2017
Last Updated: 09/26/2026